Compare RNW & LMAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | RNW | LMAT |
|---|---|---|
| Founded | 2011 | 1983 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Electric Utilities: Central | Medical/Dental Instruments |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.5B | 2.1B |
| IPO Year | 2021 | 2006 |
| Metric | RNW | LMAT |
|---|---|---|
| Price | $6.84 | $79.05 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 1 | 5 |
| Target Price | $7.00 | ★ $105.80 |
| AVG Volume (30 Days) | ★ 2.3M | 240.6K |
| Earning Date | 06-15-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 0.93% |
| EPS Growth | N/A | ★ 30.57 |
| EPS | N/A | ★ 1.42 |
| Revenue | N/A | ★ $249,602,000.00 |
| Revenue This Year | N/A | $14.21 |
| Revenue Next Year | $11.50 | $8.88 |
| P/E Ratio | ★ $14.63 | $55.96 |
| Revenue Growth | N/A | ★ 13.53 |
| 52 Week Low | $4.39 | $78.27 |
| 52 Week High | $8.24 | $118.01 |
| Indicator | RNW | LMAT |
|---|---|---|
| Relative Strength Index (RSI) | 62.54 | 37.39 |
| Support Level | $6.78 | $78.65 |
| Resistance Level | $6.85 | $83.71 |
| Average True Range (ATR) | 0.03 | 1.82 |
| MACD | -0.02 | 0.46 |
| Stochastic Oscillator | 55.00 | 15.69 |
ReNew Energy Global PLC is a developer and operator of clean energy projects. Additionally, it provides clean energy solutions and value-added energy offerings through digitalization, storage, and carbon market services that are increasingly integral to addressing climate change. The company has two reportable segments: Generation and sale of renewable power and Manufacturing of power equipment. The majority of its revenue is generated from the Generation and sale of renewable power segment, which reflects the revenue earned from its utility-scale wind energy projects, solar energy projects, and hydro energy projects. The Manufacturing of power equipment segment relates to the manufacturing of solar panels and modules. Geographically, all of its material revenues are generated from India.
LeMaitre Vascular Inc is a provider of medical devices and human tissue cryopreservation services mainly used in the treatment of peripheral vascular disease, end-stage renal disease, and cardiovascular disease. The company develops, manufactures, and markets vascular devices to address the needs of vascular surgeons and, to a lesser extent, other specialties such as cardiac surgeons, general surgeons, and neurosurgeons. Its diversified portfolio consists of branded products used in arteries and veins that are well known to vascular surgeons. It operates across the Americas, Europe, the Middle East and Africa, and Asia Pacific, with the majority of its revenue generated from the Americas.